Aspirin, Other NSAIDs Reduce PSA Levels

Doctors measure a man’s level of prostate-specific antigen (PSA) to screen for prostate cancer.  The higher the concentration of PSA, the higher the possibility of prostate cancer.  The findings of a study, published today in the medical journal, Cancer, suggests regular use of aspirin and similar non-steroidal anti-inflammatory drugs (NSAIDs) can reduce PSA levels although there is no conclusive evidence yet that regular NSAID use reduces a man’s risk of getting prostate cancer. Read more

Study Challenges Ibuprofen for Alzheimer’s Prevention, but “Something is going on”

According to a new report, Ibuprofen offers no better protection against Alzheimer’s disease than any other NSAID (non-steroidal anti-inflammatory drug). The results have challenged the most recent report that showed Ibuprofen use reduces the risk of developing Alzheimer’s disease by 23%. Study investigator, Peter P. Zandi, PhD, from Johns Hopkins Bloomberg School of Public Health, in Baltimore, Maryland, says,”This is an interesting finding, because it seems to challenge a current theory that the NSAID group that includes ibuprofen may work better in reducing a person’s risk of Alzheimer’s. Read more

Flector - Anti-inflammatory Patch Now Available

MedHeadlines - Alpharma Inc has announced the availability of FLECTOR® Patch (diclofenac epolamine topical patch) 1.3%, the first anti-inflammatory pain relief patch in the US.

Read more